Company profile: Meridian Bioscience
1.1 - Company Overview
Company description
- Provider of clinical diagnostic test kits, developing, manufacturing, marketing, and distributing assays for gastrointestinal, viral, respiratory, and parasitic infectious diseases, plus bulk antigens and antibodies. Portfolio includes BreathID Smart (H. pylori), Curian, Immunocard STAT!, Premier, Tru, and Merifluor offering rapid immunoassay, enzyme immunoassay, and fluorescent testing.
Products and services
- Curian: Rapid fluorescent immunoassay system for detecting gastrointestinal diseases, including H. pylori, Campylobacter, and Shiga Toxin E. coli (fluorescent-based)
- Immunocard STAT!: Rapid test product delivering results in 5-15 minutes for various diseases, suitable for laboratories of any size (rapid)
- Premier: Multi-step microwell-based enzyme immunoassay for detecting gastrointestinal diseases, healthcare-acquired infections, and other conditions (microwell-based)
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Meridian Bioscience
Noroit
HQ: France
Website
- Description: Provider of protective equipment against biological risks, including airflow cabinets and modules, isolators, and cabinets for animal production science, serving medical research, pharmaceutical industry and industry; products based on laminar airflow and physical containment technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Noroit company profile →
Cytoo
HQ: France
Website
- Description: Provider of life science research products and cell-based assay solutions that make cellular analysis robust and reliable by decreasing cell variability, including high content screening (96-well, 384 format coming), micropatterning technology, OncoSpheres 3D spheroids, Arena and custom chips, and standard, starter, and motility plates for high-throughput, multiplexed analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cytoo company profile →
RoosterBio
HQ: United States
Website
- Description: Provider of synthetic biology and regenerative medicine solutions, including standardized hMSC 2D (flask) and 3D (bioreactor) bioprocess systems for scalable hMSC manufacturing, industrialized exosome/extracellular vesicle production from hMSCs across bioreactor platforms, and the Boost at the Roost protocol for high-efficiency cell cargo loading to enhance cell engineering for MSC and exosome therapies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full RoosterBio company profile →
LabMinds
HQ: United States
Website
- Description: Provider of AI and robotics-driven solution preparation for pharmaceutical and life science labs, offering the accroma bufferPrep System to prepare buffers via customizable recipes, handling up to 26 chemicals with automated water dosing, solids/liquids dosing, stirring, pH adjustment, vacuum filtration, and autoclean/validation, plus cloud-based software for buffer ordering, inventory, secure data storage, and web browser control.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LabMinds company profile →
Immunologix
HQ: United States
Website
- Description: Provider of antibody-based therapeutics, producing human monoclonal antibodies targeting viral, bacterial, and tumor antigens, as well as human auto antigens.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Immunologix company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Meridian Bioscience
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Meridian Bioscience
2.2 - Growth funds investing in similar companies to Meridian Bioscience
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Meridian Bioscience
4.2 - Public trading comparable groups for Meridian Bioscience
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →